These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 9192825)

  • 41. Suppression of growth arrest and DNA damage-inducible 45alpha expression confers resistance to sulindac and indomethacin-induced gastric mucosal injury.
    Chiou SK; Hodges A; Hoa N
    J Pharmacol Exp Ther; 2010 Sep; 334(3):693-702. PubMed ID: 20498252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells.
    Shiff SJ; Qiao L; Tsai LL; Rigas B
    J Clin Invest; 1995 Jul; 96(1):491-503. PubMed ID: 7615821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PPARgamma-mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cells.
    Nikitakis NG; Hebert C; Lopes MA; Reynolds MA; Sauk JJ
    Int J Cancer; 2002 Apr; 98(6):817-23. PubMed ID: 11948457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines.
    Sangfelt O; Erickson S; Castro J; Heiden T; Einhorn S; Grandér D
    Cell Growth Differ; 1997 Mar; 8(3):343-52. PubMed ID: 9056677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nonsteroidal anti-inflammatory drugs inhibit growth of human neuroendocrine tumor cells via G1 cell-cycle arrest.
    Detjen KM; Welzel M; Wiedenmann B; Rosewicz S
    Int J Cancer; 2003 Dec; 107(5):844-53. PubMed ID: 14566837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines.
    Han EK; Arber N; Yamamoto H; Lim JT; Delohery T; Pamukcu R; Piazza GA; Xing WQ; Weinstein IB
    Breast Cancer Res Treat; 1998 Apr; 48(3):195-203. PubMed ID: 9598866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis.
    Bottone FG; Martinez JM; Collins JB; Afshari CA; Eling TE
    J Biol Chem; 2003 Jul; 278(28):25790-801. PubMed ID: 12734198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide induced gastric cancer cell apoptosis.
    Jang TJ; Kang HJ; Kim JR; Yang CH
    Carcinogenesis; 2004 Oct; 25(10):1853-8. PubMed ID: 15180942
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth.
    Williams CS; Goldman AP; Sheng H; Morrow JD; DuBois RN
    Neoplasia; 1999 Jun; 1(2):170-6. PubMed ID: 10933052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiangiogenic effect of sulindac sulfide could be secondary to induction of apoptosis and cell cycle arrest.
    Flis S; Soltysiak-Pawluczuk D; Jedrych A; Jastrzebski Z; Remiszewska M; Splawinski J
    Anticancer Res; 2006; 26(4B):3033-41. PubMed ID: 16886631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sulindac sulfone inhibits K-ras-dependent cyclooxygenase-2 expression in human colon cancer cells.
    Taylor MT; Lawson KR; Ignatenko NA; Marek SE; Stringer DE; Skovan BA; Gerner EW
    Cancer Res; 2000 Dec; 60(23):6607-10. PubMed ID: 11118042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins.
    Goldberg Y; Nassif II; Pittas A; Tsai LL; Dynlacht BD; Rigas B; Shiff SJ
    Oncogene; 1996 Feb; 12(4):893-901. PubMed ID: 8632912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential activity of sulindac metabolites against squamous cell carcinoma of the head and neck is mediated by p21waf1/cip1 induction and cell cycle inhibition.
    Bock JM; Menon SG; Goswami PC; Sinclair LL; Bedford NS; Jackson RE; Trask DK
    Cancer Biol Ther; 2007 Jan; 6(1):30-9. PubMed ID: 17172818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer.
    Babbar N; Ignatenko NA; Casero RA; Gerner EW
    J Biol Chem; 2003 Nov; 278(48):47762-75. PubMed ID: 14506281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sulindac and Celecoxib regulate cell cycle progression by p53/p21 up regulation to induce apoptosis during initial stages of experimental colorectal cancer.
    Vaish V; Rana C; Piplani H; Vaiphei K; Sanyal SN
    Cell Biochem Biophys; 2014 Mar; 68(2):301-19. PubMed ID: 23857431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The growth inhibition of colorectal adenoma cells by sulindac and its mechanisms].
    Huang L; Ouyang Q; Wei D; Liu X; Hu R
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):101-3. PubMed ID: 12599442
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulindac induces specific degradation of the HPV oncoprotein E7 and causes growth arrest and apoptosis in cervical carcinoma cells.
    Karl T; Seibert N; Stöhr M; Osswald H; Rösl F; Finzer P
    Cancer Lett; 2007 Jan; 245(1-2):103-11. PubMed ID: 16488075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells.
    Rice PL; Kelloff J; Sullivan H; Driggers LJ; Beard KS; Kuwada S; Piazza G; Ahnen DJ
    Mol Cancer Ther; 2003 Sep; 2(9):885-92. PubMed ID: 14555707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity.
    Piazza GA; Keeton AB; Tinsley HN; Gary BD; Whitt JD; Mathew B; Thaiparambil J; Coward L; Gorman G; Li Y; Sani B; Hobrath JV; Maxuitenko YY; Reynolds RC
    Cancer Prev Res (Phila); 2009 Jun; 2(6):572-80. PubMed ID: 19470791
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells.
    Yip-Schneider MT; Sweeney CJ; Jung SH; Crowell PL; Marshall MS
    J Pharmacol Exp Ther; 2001 Sep; 298(3):976-85. PubMed ID: 11504793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.